MX9204031A - SALT OF L-ASCORBATE OF 16-DESCARBOXI-16-HIDROXIMETIL-AMFOTERICINA B, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH SALT. - Google Patents

SALT OF L-ASCORBATE OF 16-DESCARBOXI-16-HIDROXIMETIL-AMFOTERICINA B, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH SALT.

Info

Publication number
MX9204031A
MX9204031A MX9204031A MX9204031A MX9204031A MX 9204031 A MX9204031 A MX 9204031A MX 9204031 A MX9204031 A MX 9204031A MX 9204031 A MX9204031 A MX 9204031A MX 9204031 A MX9204031 A MX 9204031A
Authority
MX
Mexico
Prior art keywords
salt
descarboxi
amfotericina
hidroximetil
ascorbate
Prior art date
Application number
MX9204031A
Other languages
Spanish (es)
Inventor
David Timothy Macpherson
Alexander Richard Greenlees
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9204031A publication Critical patent/MX9204031A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9204031A 1991-07-11 1992-07-09 SALT OF L-ASCORBATE OF 16-DESCARBOXI-16-HIDROXIMETIL-AMFOTERICINA B, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH SALT. MX9204031A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919114949A GB9114949D0 (en) 1991-07-11 1991-07-11 Novel compounds

Publications (1)

Publication Number Publication Date
MX9204031A true MX9204031A (en) 1993-01-01

Family

ID=10698172

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204031A MX9204031A (en) 1991-07-11 1992-07-09 SALT OF L-ASCORBATE OF 16-DESCARBOXI-16-HIDROXIMETIL-AMFOTERICINA B, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH SALT.

Country Status (7)

Country Link
AU (1) AU2230892A (en)
GB (1) GB9114949D0 (en)
IE (1) IE922264A1 (en)
MX (1) MX9204031A (en)
PT (1) PT100671B (en)
TW (1) TW199894B (en)
WO (1) WO1993001203A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
US7981998B2 (en) 2006-12-14 2011-07-19 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
AU2007333846B2 (en) 2006-12-14 2014-01-23 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
CA2939778C (en) 2007-01-31 2019-01-29 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
ES2649941T3 (en) 2007-02-23 2018-01-16 Aileron Therapeutics, Inc. Substituted amino acids to prepare triazole-linked macrocyclic peptides
KR101525754B1 (en) 2007-03-28 2015-06-09 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Stitched polypeptides
BRPI1006139A2 (en) 2009-01-14 2017-05-30 Aileron Therapeutics Inc peptidomimetic macrocycles
JP2013505300A (en) 2009-09-22 2013-02-14 エルロン・セラピューティクス・インコーポレイテッド Peptidomimetic macrocycle
SI2603600T1 (en) 2010-08-13 2019-04-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
KR20140100937A (en) 2011-10-18 2014-08-18 에일러론 테라퓨틱스 인코포레이티드 Peptidomimetic macrocycles
WO2013123267A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN104159595A (en) 2012-02-15 2014-11-19 爱勒让治疗公司 Peptidomimetic macrocycles
BR112015009470A2 (en) 2012-11-01 2019-12-17 Aileron Therapeutics Inc disubstituted amino acids and their methods of preparation and use
WO2016049355A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
KR20170058424A (en) 2014-09-24 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 Peptidomimetic macrocycles and uses thereof
AU2016235424A1 (en) 2015-03-20 2017-10-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US10059741B2 (en) 2015-07-01 2018-08-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
EP3347372A4 (en) 2015-09-10 2019-09-04 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of mcl-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8829592D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
GB8829593D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
EP0431874A1 (en) * 1989-12-08 1991-06-12 Beecham Group p.l.c. Novel compounds
EP0431870A1 (en) * 1989-12-08 1991-06-12 Beecham Group p.l.c. Amphotericin B derivatives

Also Published As

Publication number Publication date
PT100671B (en) 1999-07-30
WO1993001203A1 (en) 1993-01-21
AU2230892A (en) 1993-02-11
TW199894B (en) 1993-02-11
IE922264A1 (en) 1993-01-13
PT100671A (en) 1993-10-29
GB9114949D0 (en) 1991-08-28

Similar Documents

Publication Publication Date Title
MX9204031A (en) SALT OF L-ASCORBATE OF 16-DESCARBOXI-16-HIDROXIMETIL-AMFOTERICINA B, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH SALT.
MX9206851A (en) ORGANIC SALTS OF N, N'-DIACETIL CYSTINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9206236A (en) PHARMACEUTICAL COMPOSITIONS OF CONTROLLED RELEASE AND PROCESS FOR ITS PREPARATION.
MX9205908A (en) HETEROBIARILIC DERIVATIVES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION
ES2011210A4 (en) DERIVATIVES OF GEM-DIPHOSPHONATE SUBSTITUTED BY PHENOL, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EE03177B1 (en) Heterobicyclic compounds, methods for their preparation and pharmaceutical compositions containing said compounds
MX9206938A (en) NEW PEPTIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION THAT INCLUDES SUCH DERIVATIVES.
BR9100435A (en) COMPOUND, PHARMACEUTICAL COMPOSITION, USE, METHOD OF TREATING AN ANIMAL, PROCESSES FOR THE PREPARATION OF A COMPOUND AND PHARMACEUTICAL COMPOSITION
AR012717A1 (en) S-OMEPRAZOLE MAGNESIUM SALT TRIHYDRATE, PROCESS FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION, AND USE OF SUCH TRIHYDRATE FOR THE MANUFACTURE OF MEDICINES.
MX9202619A (en) DERIVATIVES OF OXA TIOLANO CRISTALINO, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
MX9204140A (en) NEW DERIVATIVES OF TAXOL ANALOGS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM.
MX9202748A (en) ARILETER COMPOUND, PROCESS FOR ITS OBTAINING AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9201295A (en) DERIVATIVES OF BENZOFURANO, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM.
MX9102580A (en) NEW BENZODIACEPINONAS, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9202022A (en) DERIVATIVES OF PIRAZINE AND PROCESS FOR ITS PREPARATION.
DE68909412D1 (en) SALTS OF GLYCOSAMINOGLYCANS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SALTS.
FR2663326B2 (en) PYRIDAZINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
DK0435333T3 (en) Cephalosporin derivatives, process for their preparation and antimicrobial composition containing the derivatives
MX9202300A (en) DERIVATIVES OF BENZOFURANO, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9201848A (en) ANTISEROTONINS, PROCEDURE FOR ITS PREPARATION AND MEDICINES THAT CONTAIN THEM.
DE3887068D1 (en) 2,2-Dimethylchromene derivatives, process for their preparation and pharmaceutical compositions containing them.
MX9204395A (en) DERIVATIVES OF 3-DESOXI-MANOSAMINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX9203836A (en) DERIVATIVES OF ACID-4-AMINO-3-HYDROXICARBOXILICO AND PROCESS FOR ITS PREPARATION.
FR2700956B1 (en) COSMETIC AND PHARMACEUTICAL COMPOSITION AND PROCESS FOR ITS PREPARATION.
MX9207269A (en) SUBSTITUTED BENZMIDAZOLES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.